Anti-Cancer Agents

• 收藏
• 分享

专利权人:

UEA ENTERPRISES LIMITED

发明人:

Heba ALSHAKER,Qi WANG,Shyam Srivats RASIPUR,Dmitry PSHEZHETSKIY

申请号：

US16470368

公开号：

US20200121807A1

申请日:

2017.12.19

申请国别(地区):

US

年份:

2020

代理人:

摘要：

Provided is a pharmaceutical composition comprising a taxane and a sphingosine kinase 1 (SK1) inhibitor, a kit comprising a first pharmaceutical composition comprising a taxane and a second pharmaceutical composition comprising an SK1 inhibitor, and a taxane for use in a method of treating cancer, wherein the taxane is administered simultaneously, separately or sequentially with an SK1 inhibitor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/